Anti-Cardiovascular Disease Compound Library
Cardiovascular disease generally refers to all types of diseases that affect the heart or blood vessels, including coronary heart disease (clogged arteries), which can cause heart attacks, stroke, congenital heart defects and peripheral artery disease, and is the leading cause of death for men and women in the U.S. Different types of cardiovascular diseases have different mechanisms of pathogenesis. Antioxidants, lipid-lowering agents, anti-ischemic drugs, and platelet aggregation inhibitors all can reduce cardiovascular disease risk. Some natural products can inhibit the gene expression of cell adhesion molecules, cytokine, and chemokine, inhibit the function of platelet, enhance the release of nitric oxide by endothelial cells, and inhibit the contraction of smooth muscle.
A unique collection of 1428 cardiovascular diseases related compounds by TargetMol can be used for cardiovascular diseases related research and high throughput and high content screening for new drugs.
All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Product Description
- A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS)
- Bioactivity and safety confirmed by pre-clinical research and clinical trials and most of them are approved by FDA, EMA, or NMPA
- Covers various major targets including membrane transporter, ion channel Effect tool for research in cardiovascular disease.
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description
- Structurally diverse, medicinally active, and cell permeable
- NMR and HPLC validated to ensure high purity and quality